Dosage form, device and methods of treatment

Details for Australian Patent Application No. 2004210542 (hide)

International Classifications

Event Publications

23 September 2004 Complete Application Filed

30 September 2004 Application Open to Public Inspection

Published as AU-B-2004210542

28 July 2005 Application Accepted

Published as AU-B-2004210542

3 November 2005 Opposition Lodged

Ancare New Zealand Limited has lodged an opposition against Eli Lilly and Company.

10 November 2005 Opposition Lodged

Merial Ltd has lodged an opposition against Eli Lilly and Company.

17 April 2008 Opposition Withdrawn

The opposition by Ancare New Zealand Limited against Eli Lilly and Company has been withdrawn.

11 September 2008 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 14 May 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

8 January 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 14 May 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.